The miR-137, a proven tumor suppressor in melanomas and gliomas, is downregulated in lactotroph PitNETs, especially in invasive prolactinomas, as it acts as an inhibitor of microphthalmia-associated transcription factor (MITF) and is involved in cell differentiation, proliferation, and survival [77]. Here, MITF is linked to central nervous system cancer.